New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection

Simple item page
dc.contributor.authorJourdan A. Andersson
dc.contributor.authorAlex G. Peniche
dc.contributor.authorCristi L. Galindo
dc.contributor.authorPrapaporn Boonma
dc.contributor.authorJian Sha
dc.contributor.authorRuth Ann Luna
dc.contributor.authorTor C. Savidge
dc.contributor.authorAshok K. Chopra
dc.contributor.authorSara M. Dann
dc.date.accessioned2025-07-21T06:03:13Z
dc.date.issued2020-03-09
dc.description.abstractFrequent and excessive use of antibiotics primes patients to
dc.identifier.doi10.1128/mbio.00053-20
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/9275
dc.subjectDrug repositioning
dc.subject.classificationClostridium difficile and Clostridium perfringens research
dc.titleNew Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection
dc.typeArticle

Files

Collections

All